Abstract
Real-world data comparing psoriasis treatment use in children and adults is limited. Understanding disease and treatment differences amongst these populations helps to identify potential opportunities for optimization of care. Data were drawn from the Adelphi pediatric (ages ≤17) and adult (ages ≥18) Psoriasis Disease Specific Programmes (DSP): point-in-time surveys of physicians and their psoriasis patients in the US collected in August-November 2018 (adults) and December 2019-April 2020 (pediatric).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
